Sindbis Virus
Morphology | Of the genus Alphavirus, and a member of the Togaviridae family. Virions are spherical to pleomorphic (70 nm in diameter), consisting of an envelope and nucleocapsid. The non-segmented genome consists of a single molecule of linear positive-sense single-stranded RNA |
---|---|
Disease | Epidemic polyarthritis and rash, Sindbis virus disease. |
Zoonosis | Yes, by mosquito bite. May be transmitted by ticks. |
Host Range | Humans, mosquitos, and birds |
---|---|
Modes of Transmission | Transmitted by mosquito bite. |
Signs and Symptoms | Sudden onset fever, headache, arthralgia, fatigue, and muscle pain. |
Infectious Dose | Unknown |
Incubation Period | To 10 days. |
Prophylaxis | None available |
---|---|
Vaccines | None available |
Treatment | No specific treatment; however, dioxane-based antiviral agents for treatment are under investigation. |
Surveillance | Monitor for symptoms. |
MSU Requirements | Report any exposures. |
Laboratory Acquired Infections (LAIs) | None reported to date |
---|---|
Sources | Infected mosquitoes, skin lesions and blood or serum samples. Cultures, frozen stocks, other samples described in IBC protocol. |
Canadian MSDS: | http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/bmbl/?CDC_AAref_Val=https://www.cdc.gov/labs/BMBL.html |
ECDC
|
https://www.ecdc.europa.eu/en/sindbis-fever |
NIH Guidelines
|
https://osp.od.nih.gov/wp-content/uploads/NIH_Guidelines.pdf |
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection | Susceptible to 1:10 bleach:water, 70 % ethanol |
---|---|
Inactivation | Inactivated by moist heat (15 minutes at 121° C) and dry heat (1 hour at 170° C). |
Survival Outside Host | Survive in cell culture at low temperature and low pH. Can also survive in biological materials for long periods of time. |
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |